GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Winston Pharmaceuticals Inc (GREY:WPHM) » Definitions » Net Margin %

WPHM (Winston Pharmaceuticals) Net Margin % : -145.43% (As of Mar. 2010)


View and export this data going back to 2006. Start your Free Trial

What is Winston Pharmaceuticals Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Winston Pharmaceuticals's Net Income for the three months ended in Mar. 2010 was $-0.46 Mil. Winston Pharmaceuticals's Revenue for the three months ended in Mar. 2010 was $0.32 Mil. Therefore, Winston Pharmaceuticals's net margin for the quarter that ended in Mar. 2010 was -145.43%.

The historical rank and industry rank for Winston Pharmaceuticals's Net Margin % or its related term are showing as below:


WPHM's Net Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 3.665
* Ranked among companies with meaningful Net Margin % only.

Winston Pharmaceuticals Net Margin % Historical Data

The historical data trend for Winston Pharmaceuticals's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Winston Pharmaceuticals Net Margin % Chart

Winston Pharmaceuticals Annual Data
Trend Sep05 Sep06 Sep07 Dec08 Dec09
Net Margin %
- - - -1,135.10 -190.32

Winston Pharmaceuticals Quarterly Data
Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -229.12 -167.67 -200.00 -165.78 -145.43

Competitive Comparison of Winston Pharmaceuticals's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Winston Pharmaceuticals's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Winston Pharmaceuticals's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Winston Pharmaceuticals's Net Margin % distribution charts can be found below:

* The bar in red indicates where Winston Pharmaceuticals's Net Margin % falls into.



Winston Pharmaceuticals Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Winston Pharmaceuticals's Net Margin for the fiscal year that ended in Dec. 2009 is calculated as

Net Margin=Net Income (A: Dec. 2009 )/Revenue (A: Dec. 2009 )
=-2.655/1.395
=-190.32 %

Winston Pharmaceuticals's Net Margin for the quarter that ended in Mar. 2010 is calculated as

Net Margin=Net Income (Q: Mar. 2010 )/Revenue (Q: Mar. 2010 )
=-0.461/0.317
=-145.43 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Winston Pharmaceuticals  (GREY:WPHM) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Winston Pharmaceuticals Net Margin % Related Terms

Thank you for viewing the detailed overview of Winston Pharmaceuticals's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Winston Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
100 North Fairway Drive, Suite 134, Vernon Hills, IL, USA, 60061
Winston Pharmaceuticals Inc is a pharmaceutical company, which is engaged in the discovery and development of products for pain management. The company focuses on major pain indications such as episodic cluster headache, chronic migraine headache, neuropathic pain syndromes, osteo- and rheumatoid arthritis, and pain and inflammation in inflammatory bowel disease.
Executives
Frost Phillip Md Et Al 10 percent owner 4400 BISCAYNE BLVD, MIAMI FL 33137-3227
Frost Gamma Investments Trust 10 percent owner 4400 BISCAYNE BLVD, MIAMI FL 33137
Subbarao V Uppaluri director 4400 BISCAYNE BOULEVARD, SUITE 1500, MIAMI FL 33137
Curtis Lockshin director 4400 BISCAYNE BOULEVARD, SUITE 950, MIAMI FL 33137
Glenn L Halpryn director 4400 BISCAYNE BOULEVARD, SUITE 950, MIAMI FL 33137
Steven Jerry Glauser 10 percent owner 1428 BRICKELL AVENUE, SUITE 105, MIAMI FL 33131
Noah M Silver director, officer: Vice President 4400 BISCAYNE BOULEVARD, SUITE 950, MIAMI FL 33137
Alan Jay Weisberg director, officer: Chief Financial Officer 2500 NORTH MILITARY TRAIL, SUITE 206, BOCA RATON FL 33431
Stephen Bittel 10 percent owner 4400 BISCAYNE BOULEVARD SUITE 950 MIAMI FL 33137

Winston Pharmaceuticals Headlines

No Headlines